期刊文献+

HIV-1B亚型gp120基因密码子优化前后免疫原性的比较 被引量:8

Study on the Immunogenicity of HIV-1 Clade B gp120 Gene before and after Codon Optimization
下载PDF
导出
摘要 对HIV 1B亚型gp120基因按照哺乳动物优势密码子的使用原则进行优化,以Westernblot方法比较其体外表达量。将优化前的野生型gp120基因和改造后的modgp120基因插入重组腺伴随病毒载体,构建了重组病毒rAAV wtgp120和rAAV modgp120,比较两者免疫Balb/C小鼠后的抗体和CTL应答。Westernblot检测结果显示:优化后基因的体外表达量明显高于野生型基因,rAAV modgp120与rAAV wtgp120相比可更好地诱导Balb/C小鼠的CTL应答,但检测不到明显的抗体反应。由此得出结论,优化后gp120基因的体外表达量明显高于野生型基因,并且可以诱导更强的特异性CTL应答,但检测不到gp120抗体。 To compare the immunogenicity of HIV-1 clade B gp120 gene using optimized codons with wild-type gene based on recombinant adeno-associated virus vector(rAAV),we,firstly,generated a synthetic HIV-1 gp120 sequence in which most wide-type codons were replaced with codons from highly expressed human genes(modgp120) and identified its better expression in vitro than that of wild-type gene(wtgp120)using Western blot;secondly,we inserted wtgp120 and modgp120 into rAAV vector and produced pure rAAV-wtgp120 and rAAV-modgp120.Balb/C mice were immunized with rAAV-wtgp120 and rAAV-modgp120 separately,the antibody and CTL responses were tested.Results indicated that modgp120 gene expressed more antigen in vitro and induced higher specific CTL response in vivo than that of wild-type gp120 gene.There was no detectable antibody to gp120.
出处 《病毒学报》 CAS CSCD 北大核心 2004年第3期214-217,共4页 Chinese Journal of Virology
基金 中国综合性艾滋病研究项目(CIPRA) 国家863计划(编号:2001AA215031)
关键词 人免疫缺陷病毒I型 HIV-1 GP120 基因 密码子 免疫原性 重组腺伴随病毒 HIV-1 optimized codon usage recombinant adeno-associated virus CTL response
  • 相关文献

参考文献10

  • 1Goulder P J, Brander C, Tang Y, et al. Evolution and transmission of stable CTL escape mutations in HIV infection [J ]. Nature, 2001,412:334 - 338.
  • 2Chouquet C, Autran B, Gomard E, et al. Correlation between breadth of memory HIV-specific cytotoxic T cells,viral load and disease progression in HIV infection[J]. AIDS,2002,16:2399 - 2407.
  • 3Cmarko D, Boe S O, Scassellati C, et al. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs[J ]. J Virol, 2002,76:10473 - 10484.
  • 4Kong W,Tian C J, Liu B D, et al. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic Sindbis virus vector[ J ]. J Virol, 2002,76:1143411439.
  • 5Zolotukhin A S, Michalowski D, Bear J, et al. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression[ J ]. Mol Cell Biol,2003,23: 6618 - 6630.
  • 6Andre S, Seed B, Eberle J, et al. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage[ J ]. J Virol, 1998,72:1497 - 1503.
  • 7Xin K Q, Urabe M, Yang J, et al. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus[J]. Hum Gene Ther, 2001,12:1047- 1061.
  • 8Klinman D M, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines [ J ]. J Immunol,1997,158: 3635 - 3639.
  • 9伍志坚,吴小兵,曹晖,董小岩,王宏,侯云德.一种高效的重组腺伴随病毒载体生产系统[J].中国科学(C辑),2001,31(5):423-430. 被引量:36
  • 10邹蓓艳,陈立,伍志坚,吴小兵,卢大儒,邱信芳,薛京伦.肌注腺伴随病毒基因治疗血友病B的安全性研究[J].病毒学报,2001,17(4):301-306. 被引量:2

二级参考文献11

共引文献37

同被引文献117

引证文献8

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部